UGGT activity decreases in <i>uggt-1(RNAi)</i> worms but no decrease was observed in <i>uggt-2 (RNAi)</i> worms. by Lucila I. Buzzi (198284)

GIRK2^AgRP-KO mice show decreased EE associated with BAT dysfunction and decreased sympathetic activity. by Youjin Oh (3308670)

Arginine supplementation decreases the inhibitory effect exerted by 5-flucytosine in <i>C</i>. <i>glabrata</i>. by Catarina Costa (322963)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

Meta-analytical results of secondary outcomes. by Maria-Sophie Brueckle (13816408)

Subjects:

Study characteristics. by Maria-Sophie Brueckle (13816408)

Subjects:

Forest plots of primary outcomes. by Maria-Sophie Brueckle (13816408)

Subjects:

Effects of the adipokines resistin, visfatin, leptin, and adiponectin on androstenedione production <i>in</i><i>vitro</i> in the presence of LH: compared to control cells, adiponectin treatment (3μg/mL) decreased levels of androstenedione in medium (****p= <0.0001) when bovine theca cells were treated with LH and insulin (both at 100 ng/mL). by Fabio V. Comim (486376)

The prevalence of hypertension, diabetes, metabolic syndrome, cardiovascular disease and decreased GFR according to the following age groups: 60–69, 70–79 and ≥80 years. by Regina C. R. M. Abdulkader (302450)

“…Diabetes mellitus: self-reported or a fasting plasma glucose ≥126 mg/dL or a glycohemoglobin ≥6.5%. …”

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

Lytic reactivation stimuli decrease Oct-2 expression. by Amanda R. Robinson (184305)

“…The amount of Oct-2 protein expression was quantitated using ImageJ software and represented as a numerical value below the Oct-2 immunblot. The Oct-2 protein level in untreated cells infected with the control lentivirus was set at 100.…”

Means and 95% confidence interval (CI) of all costs, benefits, and the difference in net benefits from the probabilistic reference case given in 2019 USD for 3 years for a 100-cow... by Marlena Waldbauer (18291223)

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

Aβ and 22C11 agonist decreased cholesterol uptake whereas the sAPP-derived peptide and SM-ϕ stimulated increased cholesterol uptake by Caco-2 cells. by Kendra L. Puig (334788)

IL-18 decreases TEER in Caco2 monolayers. by Ossama Allam (5043434)

“…<p>The TEER was measured during 24 hours after addition of 10 ng/ml of IL-18, 10 ng/ml IL-1β or 100 ng/ml Tat to the cell monolayers. …”

Imatinib decreases <i>in vivo</i> proliferation of T-cells. by Ludovic Belle (293091)

Vinpocetine inhibits carrageenan-induced decrease in antioxidant capacity. by Kenji W. Ruiz-Miyazawa (714809)

The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

“…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”

miR-24 levels decrease with replicative senescence. by Ashish Lal (43926)